The number and distribution of nanoprobes coated with the breast cancer drug Herceptin and inserted into live human tumor cells in the lab have been measured by Purdue University researchers.

Targeting only tumor cells with nanoprobes would require less drugs and mitigate the side effects of cancer chemotherapy drugs, they suggest. Cancer treatments often use high drug concentrations that damage healthy cells near a tumor.